Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MYL12B pseudogene 1 (MYL12BP1) likely refers to a pseudogene of the MYL12B gene. Pseudogenes are genomic DNA sequences similar to normal genes but are generally non-functional, either due to mutations preventing their expression or because they do not encode functional proteins[6]. MYL12B itself is a protein-coding gene ("myosin light chain 12B, regulatory") involved in regulating the activity of nonmuscle myosin II via phosphorylation[2][3][5]. However, MYL12BP1 is not a characterized gene or therapeutic target in literature and is not associated with known protein product, molecular function, disease role, or interacting drugs. There is also no evidence to support its use as a biomarker or that it poses relevant safety concerns. Most resources, including genetic and protein databases, only document the protein-coding MYL12B and not MYL12BP1. The designation "pseudogene" indicates it is not a conventional target for drug development or disease intervention[6]. Key points: - MYL12BP1 is not a therapeutic target and does not encode a functional receptor, enzyme, transporter, or other protein product. - The entry is likely incorrect or not useful for target-based drug discovery; information about the actual functional gene should refer to MYL12B ("myosin light chain 12B, regulatory")[2][3][5]. - No functional data available: As a pseudogene, it does not participate in known biological functions, disease roles, or pharmacological mechanisms. If you are seeking information about the functional protein/gene, please refer to MYL12B (myosin light chain 12B, regulatory)[2][3][5]. If you specifically require information on the pseudogene, available data indicates it is non-functional and not a conventional drug target[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MYL12B pseudogene 1 (MYL12BP1).